- £1.09m
- -£0.37m
- £0.03m
UK's ValiRx half-year loss narrows, cash position improves
Half-year Financial Report
Cytolytix Patent Update
Final Results & Notice of AGM
Brief: ValiRx Reports Cytolytix Patent Granted
Result of Oversubscribed WRAP Retail Offer
Fundraising of up to £1,155,000
ValiRx Commercial Update Q1 2026
Director/PDMR Shareholding
Exercise of Warrants
New Evaluation and Material Transfer Agreement
Holding(s) in Company
Holding(s) in Company
Holding(s) in Company
Holding(s) in Company
Holding(s) in Company
Holding(s) in Company
Posting of Circular and Notice of General Meeting
Result of WRAP Retail Offer